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BACKGROUND: Despite known benefits of influenza vaccination and
coverage by Medicare Part B, elderly minority patients are less likely to
receive influenza vaccination than whites.
OBJECTIVES: To test whether a nonphysician-initiated standardized
offer of influenza vaccination to all elderly primary care patients would
result in similar proportions of African-American and white patients
accepting vaccine.
DESIGN: In 7 metropolitan Detroit primary care practices during the
2003 influenza vaccination season, medical assistants assessed influ-
enza immunization status of all patients 65 years and older and col-
lected limited demographic data. Eligible patients were offered
vaccination.
MEASUREMENTS: Proportion of patients accepting influenza vaccina-
tion by race and predictors of vaccine acceptance.
RESULTS: Four hundred and fifty-four eligible patients with complete
racial information were enrolled: 40% African American, 52% white, 8%
other race/ethnicity. Similar proportions of African Americans and
whites had already received the 2003 vaccine (11.6% and 11.0%, re-
spectively) or stated vaccination as the reason for visit (23.8% and
30.5%, respectively). Among the remainder, there also were similar
proportions who accepted vaccination: 68.9% white and 62.1% African-
American patients. History of previous vaccination was the only statis-
tically significant predictor of vaccine acceptance (odds ratio [OR] 8.64,
95% confidence interval [CI] 4.17, 17.91, Po.001). After adjusting for
history of previous vaccination, age, gender, and education, the odds of
vaccine acceptance were no different for whites and African Americans
(OR 1.20, 95% CI 0.63, 2.29, P=.57).
CONCLUSIONS: Vaccination acceptance differed little between Afri-
can-American and white elderly patients. Using nonphysician person-
nel to identify and offer influenza vaccine to eligible patients is easily
accomplished in primary care offices and has the potential to eliminate
racial disparities in influenza vaccination.
KEY WORDS: health care delivery; influenza; vaccination; race/
ethnicity; underserved populations; disparities.
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A nnual influenza vaccination decreases influenza-associ-ated morbidity and mortality in the elderly,1–3 and is rec-
ommended for all persons 50 years and older by the Advisory
Committee on Immunization Practices.4 Furthermore, Medi-
care Part B has provided coverage for influenza vaccine and
administration since 1993.5 Despite the benefit and afford-
ability of influenza vaccination, many elderly adults are not
vaccinated.
According to the most recent National Health Interview
Survey (NHIS), 65.5% of adults 65 years and older received
influenza vaccination in the previous 12 months,6 short of the
Healthy People 2010 goal of 90%.7 Multiple sources including
the NHIS, the Behavioral Risk Factor Surveillance Survey, and
the Medical Expenditures Panel Survey indicate that influenza
vaccination rates are lower among minority adults than among
white adults.6,8,9 All consistently indicate that influenza vac-
cination among African Americans is 15 to 20 percentage
points less than among whites. For example, in the 2003 NHIS
(the most recent full year available), 68.6% of whites had a flu
shot within the past year, while 47.7% of blacks and 45.4% of
Hispanics reported having a flu shot.
Predictors of vaccination acceptance include physician
recommendation, patient attitudes, and beliefs about the vac-
cine, patient’s perceived susceptibility to influenza, and their
belief about the potential serious nature of acute influenza,10–15
but it is unknown whether or to what extent these factors differ
between racial/ethnic groups. Several studies have deter-
mined that the observed racial/ethnic disparities are not
fully explained by socioeconomic status and access to health
care8,16–19, leading some to hypothesize that differences in at-
titudes regarding vaccine may explain the observed dispari-
ties.8,16,19,20 Because it has been demonstrated that nurse-
initiated pneumococcal and influenza vaccination improves
vaccination rates in the outpatient setting21,22, the objective
for this project was to test the hypothesis that a medical as-
sistant (MA)-initiated universal standardized offer of influenza
vaccination to a racially diverse group of elderly primary care
patients would result in a similar number of African-American
and white patients accepting vaccine.
METHODS
Setting
The data were collected prospectively during the influenza
vaccination season of 2003. Seven offices that are members
of MetroNet, the metropolitan Detroit practice-based research
network, participated in data collection, which began in Octo-
ber 2003 and ended in early January 2004. The 7 offices were
invited to participate because all have racially/ethnically di-
verse patient populations. Three of the offices are located in
federally designated medically underserved areas (MUA) and
another office borders an MUA. One of the offices is a residen-
cy-training site, 2 are single provider sites, and the remaining
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offices are group provider sites. None of the participating of-
fices had a ‘‘standing orders’’ policy of influenza vaccination of
all elderly patients before this study, that is, MAs or other staff
were not authorized to assess a patient’s need for vaccination
and administer it. Although the study was designed to collect
data through January 2004, the offices had exhausted their
supply of vaccine before the expected end date. In fact, the en-
tire State of Michigan experienced a shortage of vaccine due
to a high demand after the publication of early influenza
outbreaks in Texas and Colorado.23
Subjects
All patients who were 65 years and older and seen at one of the
participating MetroNet offices were eligible to participate. Eli-
gible patients were identified at registration by the office staff
and a data collection form was placed on their chart at
registration.
Intervention
Participation in the study involved several steps conducted by
office staff. All staff received training in the protocol before im-
plementation at a given office. After the front desk verified the
patient’s age, the data collection form was placed on the chart.
When eligible patients were taken to the examination room, the
MA asked a series of questions:
(1) ‘‘What is the reason for your visit today?’’ The MA then
recorded whether receipt of influenza vaccination was
the reason for the visit.
(2) If the patient’s reason for visit was for something other
than influenza vaccination, the MA asked, ‘‘Would you like
your flu shot today?’’ Replies were categorized as ‘‘yes,’’
‘‘no,’’ ‘‘unsure,’’ ‘‘already received,’’ and ‘‘already partici-
pated in study’’ (for those patients who attended clinic
more than 1 time during the course of the study).
(3) The MA then asked the patient to answer several brief
questions as part of a study about influenza vaccination.
The MA read an IRB-approved statement about the pur-
pose of the study and the rights of participants in the
study. Patients who agreed to participate were asked to
provide their age, race, education level, whether they had
ever received a flu shot and approximately how many years
before, and whether they had been previously diagnosed
with 5 different medical conditions. Those patients who
indicated they did not want a flu shot were asked to pro-
vide a reason.If patients did not agree to participate in the
questions, the MA recorded the observed race and gender
of the patient on the form without asking the questions.
(4) For those patients who stated they did not want influenza
vaccination, the physician had the option to address the
patient’s concerns and recommend vaccination. Patients
who accepted vaccination after the physician’s recommen-
dation were counted as accepting vaccine.
The protocol was approved by the Wayne State University
Human Investigation Committee, and the respective Institu-
tional Review Boards of participating offices. We received ap-
proval to conduct the ‘‘standing orders’’ portion of the protocol,
i.e., identification of eligible patients and offer of influenza vac-
cine under a waiver of consent. A verbal consent was needed
for the MA to ask the patient demographic questions about
age, education, and race; previous vaccine history; and rea-
sons for refusal.
Data Analysis
Comparisons between proportions of African-American, white,
and other race/ethnicity patients regarding acceptance of in-
fluenza vaccination offer and the other variables were per-
formed using the w2 test. We estimated that approximately 300
previously unvaccinated patients (50% African American, 50%
white) were needed to detect a 15% difference in vaccine ac-
ceptance (2-tailed a=0.05, b=0.80). Univariate and multivari-
ate logistic regression analyses were conducted to determine
factors associated with vaccine acceptance, which are reported
as odds ratios.
RESULTS
The intervention was given to 484 patients. Fifteen had previ-
ously participated in the study and 8 were age ineligible, re-
sulting in 461 eligible patients. For 40 patients, the race was
provided by the MA because the patient did not agree to par-
ticipate in the verbal questionnaire portion of the study (n=10)
or because the patient did not provide race when asked. Seven
patients were missing race information from either source and
were excluded from the analysis, for a total of 454 participants
with either self-reported or MA-observed race. The study sam-
ple was 181 (40%) African-American patients, 236 (52%) white
patients, and 37 (8%) patients of other race/ethnicities.
Among the self-identified other group, the largest proportions
were other not specified (53%), followed by Hispanic or Latino
(39%), and Asian (8%).
Patients were compared by demographic characteristics,
medical history, and previous vaccination (Table 1). There
were a smaller percentage of African Americans in the young
age group (P=.01). Patients in the other race/ethnicity cate-
gory had a lower education level when compared with whites
and African Americans (Po.001). Both African-American
and other race/ethnicity patients were more likely to report a
history of diabetes than white patients (P=.01). There was
no statistical difference in the proportion of each racial group
who reported ever having received influenza vaccination:
80.1% for African-American, 85.2% for white, and 78.4% for
other.
Patients also were asked how many years had elapsed
since their last influenza vaccination if they reported ever hav-
ing received one. Although there were many missing respons-
es, significantly fewer African Americans (29.8%) reported
vaccination in the previous season than whites (45.3%)
(P=.01) (Table 2). Owing to the small number of study partic-
ipants in the other race/ethnicity category for the outcomes in
Table 2, the comparisons were restricted to African-American
and white participants.
Similar proportions of African-American and white
patients had already received the current vaccine before their
visit (11.6% and 11.0%, respectively), or stated vaccination as
the reason for visit (23.8% and 30.5%, respectively). Vaccina-
tion acceptance among those who had not already received
vaccine or had a reason for visit other than vaccination was the
test of the standardized offer; 62.1% of African Americans and
68.9% of whites accepted vaccination. This difference was not
statistically significant.
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After excluding those patients who had already received the
current vaccine and those who stated vaccination as a
reason for visit, the univariate logistic regression analysis
indicated that the only statistically significant predictor for
influenza vaccine acceptance was a prior history of receiving
influenza vaccine (Table 3). The odds of vaccine acceptance
were nearly 9 times greater among those with previous vacci-
nation (odds ratio [OR] 8.64, 95% confidence interval [CI] 4.17,
17.91, Po.001). In a multivariate analysis that adjusted
for history of previous vaccination, age, gender, and educa-
tion, the odds of vaccine acceptance were no different for
whites and African Americans (OR 1.20, 95% CI 0.63, 2.29,
P=.57).
Patients who refused vaccination (n=73; 37 African
American and 36 white) were asked why they did not want
vaccination. They were given a list of possible responses; how-
ever, many responded without prompting and more than 1 re-
sponse was allowed if given. A total of 75 responses were
collected; 13 people did not provide a response. The most com-
mon reason (given by 48.6% of African-American and 41.6% of
white patients) for not accepting flu vaccine was previously
getting sick from the flu shot (Table 4). Reasons for not wanting
vaccination were similar for African Americans and whites.
Physicians had the option of addressing the concerns ex-
pressed by patients who did not accept vaccine. For 59 pa-
tients, the physician attempted to change the patient’s mind
by addressing concerns about vaccination; 16 (27%) patients
then did agree to influenza vaccination. A similar proportion of
African-American (24%) and white (22%) patients were per-
suaded by their physician. Also, the reasons for not wanting
vaccination were similar among those whom the physicians
were able to convert and those who continued to decline
vaccine (data not shown).
DISCUSSION
Our results indicate that a MA-initiated standardized offer of
influenza vaccination to all elderly patients in primary care of-
fices will result in similar acceptance of vaccine by African-
American and white patients. This, to our knowledge, is the
Table 1. Demographic Characteristics, Previous Influenza Vaccination, and Medical History of Participants by Race. (n=454)
Characteristic African American (n=181) White (n=236) Other (n=37) w2 P-Value
n %w n %w n %w
Demographics
Gender .06
Female 111 61.3 119 50.4 17 46.0
Male 63 34.8 106 44.9 17 46.0
Missing 7 3.9 11 4.7 3 8.1
Age group (y) .01
65–74 80 44.2 128 54.2 26 70.3
75 88 48.6 92 39.0 7 18.9
Missing 13 7.2 16 6.8 4 10.8
Education level o.001
Less than high school 45 24.9 44 18.6 22 59.5
High school diploma 70 38.7 104 44.1 8 21.6
Beyond high school 55 30.4 72 30.5 3 8.1
Missing 11 6.1 16 6.8 4 10.8
Medical history
Ever had a flu shot .21
Yes 145 80.1 201 85.2 29 78.4
No 27 14.9 22 9.3 5 13.5
Missing 9 5.0 13 5.5 3 8.1
History of anemia .86
Yes 8 4.4 13 5.5 2 5.4
No 166 91.7 211 89.4 32 86.5
Missing 7 3.9 12 5.1 3 8.1
History of lung disease .75
Yes 16 8.8 16 6.8 3 8.1
No 158 87.3 208 88.1 31 83.8
Missing 7 3.9 12 5.1 3 8.1
History of kidney failure .99
Yes 5 2.8 6 2.5 1 2.7
No 169 93.4 218 92.4 33 89.2
Missing 7 3.9 12 5.1 3 8.1
History of diabetes .01
Yes 57 31.5 40 17.0 11 29.7
No 117 64.6 184 78.0 23 62.2
Missing 7 3.9 12 5.1 3 8.1
History of heart disease .42
Yes 41 22.7 66 28.0 9 24.3
No 133 73.5 158 67.0 25 67.6
Missing 7 3.9 12 5.1 3 8.1
w2 P-values do not include the missing category.
wColumn percentages.
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first study examining the impact of a standardized offer on in-
fluenza vaccine acceptance by race/ethnicity. In 1999, the
Centers for Disease Control and Prevention, in its report on
recommendations of the Task Force on Community Preventive
Services for vaccine-preventable diseases, strongly recom-
mended the use of nonphysician medical personnel to identi-
fy and offer vaccine to eligible patients to increase vaccination
rates.24 Our study used receptionists for the identification of
elderly patients and the MA offered them the vaccine. We found
no difference in acceptance rate between African-American
and white patients; however, the small sample size of patients
who were not already vaccinated and did not present for vac-
cination may partially account for the lack of statistical signif-
icance. Even so, the racial difference in vaccine acceptance
(6.8%) among those patients who had not previously received
or presented for vaccine contrasts sharply with the nationally
observed racial difference in vaccine acceptance.
Previous investigations of the disparity in influenza vac-
cination between elderly and other high-risk African-American
and white patients, estimated to be as high as 21.6% in one
study of Medicare beneficiaries,25 postulated multiple reasons
for the lower vaccination rates among African Americans.
These reasons include less health care access, lower rates of
health insurance, lower socioeconomic status (SES),8,16,25,26
resistant attitudes, and beliefs regarding vaccination (such as
vaccination causes influenza or vaccine side effects),10,26 con-
cern about vaccine contents,10 and discriminatory behavior by
providers.26 Racial disparity in influenza vaccination appears
to be independent of or only minimally explained by health
care access, health insurance, SES,16,19,25,26 provider dis-
crimination,26 and concern about vaccine contents.10 In a
large study of Medicare beneficiaries, Hebert et al.26 postulat-
ed that resistance to vaccination may be partially responsible
for the lower vaccination rate among African Americans. In the
same study, African-American patients were less likely to visit
their physician for the purpose of vaccination. This was similar
to what we observed, although the difference in our study did
not reach statistical significance.
Our finding that a history of previous influenza vaccina-
tion is a significant predictor of acceptance of influenza vacci-
nation is similar to the findings of others.10,27 Also in
agreement with previous studies, we found that a common
reason for nonacceptance of influenza vaccination is concern
regarding ill effects from the vaccine.10,14,20,27 If the physician
addresses these concerns and recommends the vaccine, some
patients will change their minds, as we and others found.28
Although it appears that African Americans and whites
accepted vaccination at similar rates under this MA-initiated
protocol, the increased publicity related to the early cases of
influenza in fall 200323 resulted in heightened demand for in-
fluenza vaccination. This may have contributed to our results
if it led to a greater desire for vaccination among African Amer-
icans compared with previous years. However, data from the
2004 National Health Interview Survey,29 largely reflecting
vaccination received in fall 2003, showed no reduction in dis-
parities nationwide, suggesting that our results were probably
not affected by the national publicity. Although the MA racially
identified forty of the patients, agreement occurred for 94.3%
of the 383 African-American and white patients with MA- and
self-identified race (95.8% for whites and 92.3% for African
Americans). We also are unable to determine whether our
standardized offer increased acceptance of vaccination among
the participants compared with the preceding year. Although
there does appear to be an increase in the proportion of pa-
tients receiving influenza vaccination in 2003 compared with
2002 (75.6% vs 48.2% for African Americans, and 82.0% vs
67.7% for whites, after excluding missing data), data on 2002
vaccination acceptance were missing for a substantial propor-
tion of patients. Determining whether standing orders in-
creased vaccination rates in these practices was not,
however, the purpose of the study.
A strength of this study is its setting in primary care of-
fices that serve racially and socioeconomically diverse popu-
lations. Half of the sites were either located in or near a
federally designated medically underserved area. The inter-
vention was easy to institute; none of the offices offered sug-
gestions or complaints regarding the protocol during regularly
scheduled visits by the research assistant while the study was
in progress or at the conclusion of the study. Although we did
not collect data on the time requirements or disruption to clin-
ic flow for the intervention, we observed that it took only a few
seconds at the reception desk to identify an eligible patient by
birth date, and an additional few seconds for the MA to inquire
whether the patient had already received a flu shot and wanted
a vaccination at that visit. Although there was a potential
disruption to patient flow if more than the usual number of
vaccinations were given over a discreet time period, such dis-
ruption was not offered as a complaint by any of the sites in-
volved in this study.
The Institute of Medicine’s Unequal Treatment report calls
for promoting consistency and equality of care through use of
evidence-based guidelines.30 For immunizations and other
Table 2. Vaccination Outcomes by Race





n % n %
Reported vaccination in the
previous season
.01
Yes 54 29.8 107 45.3
No or never vaccinated 58 32.1 58 24.6




Yes 43 23.8 72 30.5
No 136 75.1 161 68.2
Missing 2 1.1 3 1.3
Already received current
vaccine prior to visit
.87
Yes 21 11.6 26 11.0
No 159 87.8 207 87.7
Missing 1 0.6 3 1.3
Vaccine acceptedw .26
Yes 72 62.1 93 68.9
No or unsurez 44 37.9 42 31.1
Total vaccinated‰ .11
Yes 136 75.6 191 82.0
No or unsure 44 24.4 42 18.0
w2 P-values do not include the missing category.
wExcludes patients who stated vaccine as reason for visit or had re-
ceived current vaccine before visit.
zIncludes patients who refused vaccine (n=73) or stated they were
unsure if they wanted to receive it (n=13).
‰Includes all patients who were eligible to accept vaccine, including
those who stated that the vaccine was reason for visit and those
patients who had previously received vaccine.
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preventive services, implementation of systems changes has
been found to be the most effective means of improving service
delivery.31 Use of a standing orders approach, such as that
implemented here, ensuring systematic assessment and offer-
ing of services, is an example of systems change. Zimmerman
et al.20 found no differences in influenza vaccination rates by
race/ethnicity in Veterans Affairs (VA) patient populations.
While VA patients may not be representative of all patients, it
is notable that the VA system has implemented a multifaceted
approach including standing orders and patient and provider
reminders. Other studies have shown that a standing orders
type intervention at the level of the ambulatory practice is ef-
fective in improving influenza vaccination rates when com-
pared with no standing orders21 or patient and physician
reminders.22
Table 3. Odds of Vaccine Acceptance by Demographics and Medical History Among African-American and White Subjects (Univariate
Analyses, N=255).
Characteristic Vaccine Acceptance
Yes (n=165) No or Unsure (n=86) Missing (n=4)
n %w n %w n %w Odds Ratioz 95% CI P-Value
Demographics
Race
African American 72 61.5 44 37.6 1 0.9 1.0
White 93 67.4 42 30.4 3 2.2 1.35 0.80, 2.28 .26
Gender
Female 94 67.6 45 32.4 0 0.0 1.0
Male 68 66.0 35 34.0 0 0.0 0.93 0.54, 1.60 .07
Missing 3 23.1 6 46.2 4 30.8
Age group (y)
65–4 78 62.9 43 34.7 3 2.4 1.0
75 80 72.1 30 27.0 1 0.9 1.47 0.84, 2.58 .18
Missing 7 35.0 13 65.0 0 0.0
Education level
Less than high school 39 67.2 18 31.0 1 1.7 1.0
High school diploma 75 66.4 35 31.0 3 2.7 0.99 0.50, 1.97 .98
Beyond high school 47 71.2 19 28.8 0 0.0 1.07 0.73, 1.57 .74
Missing 4 22.2 14 77.8 0 0.0
Medical history
Ever had a flu shot
Yes 151 76.7 43 21.8 3 1.5 8.64 4.17, 17.91 o.001
No 13 28.3 32 69.6 1 2.2 1.0
Missing 1 8.3 11 91.7 0 0.0
History of anemia
Yes 10 58.8 7 41.2 0 0.0 0.64 0.23, 1.74 .38
No 155 68.0 69 30.3 4 1.8 1.0
Missing 0 0.0 10 100.0 0 0.0
History of lung disease
Yes 13 61.9 8 38.1 0 0.0 0.73 0.29, 1.84 .50
No 152 67.9 68 30.4 4 1.8 1.0
Missing 0 0.0 10 100.0 0 0.0
History of kidney failure
Yes 6 75.0 1 12.5 1 12.5 2.83 0.34, 23.93 .34
No 159 67.1 75 31.7 3 1.3 1.0
Missing 0 0.0 10 100.0 0 0.0
History of diabetes
Yes 46 74.2 14 22.6 2 3.2 1.71 0.87, 3.35 .12
No 119 65.0 62 33.9 2 1.1 1.0
Missing 0 0.0 10 100.0 0 0.0
History of heart disease
Yes 58 75.3 19 24.7 0 0.0 1.63 0.88, 2.99 .12
No 107 63.7 57 33.9 4 2.4 1.0
Missing 0 0.0 10 100.0 0 0.0
Includes patients who refused vaccine (n=73) or stated they were unsure whether they wanted to receive it (n=13).
wRow percentages.
zOdds ratio does not include individuals with missing data for vaccine acceptance.






I got sick from the flu shot 18 15
I know someone who got sick from the
flu shot
5 5
I’m afraid of side effects 3 5
Flu shot won’t prevent the flu 1 3
I’m afraid of needles and shots 2 1
I just don’t want it 4 3
Flu is not a serious disease 1 4
I won’t get the flu 3 2
Not all refusers provided a response; multiple responses were allowed.
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In conclusion, we found that a MA-initiated standardized
universal offer of influenza vaccine to elderly patients resulted
in similar acceptance of vaccine among a racially and socioe-
conomically diverse group of primary care patients. Use of a
standing orders-type policy that uses nonphysician personnel
to identify vaccine-eligible patients and to offer vaccine to
those patients is easily accomplished in primary care offices
that serve elderly patients, and has the potential to eliminate
the observed racial disparity in influenza vaccination in this
age group.
Funded in part by AAMC/CDC cooperative grant U36/
CCU319276 CFDA 93.283.
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